BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29608227)

  • 1. Estimating Long-Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes.
    Révész D; Fröjd V; Rydenhag B; Ben-Menachem E
    Neuromodulation; 2018 Dec; 21(8):797-804. PubMed ID: 29608227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.
    Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T
    Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Is it the Stimulation or Medication?
    Arcand J; Waterhouse K; Hernandez-Ronquillo L; Vitali A; Tellez-Zenteno JF
    Can J Neurol Sci; 2017 Sep; 44(5):532-537. PubMed ID: 28862106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland).
    Kopciuch D; Barciszewska AM; Fliciński J; Zaprutko T; Kus K; Steinborn B; Nowakowska E
    Acta Neurol Belg; 2020 Feb; 120(1):115-122. PubMed ID: 31721076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children.
    Orosz I; McCormick D; Zamponi N; Varadkar S; Feucht M; Parain D; Griens R; Vallée L; Boon P; Rittey C; Jayewardene AK; Bunker M; Arzimanoglou A; Lagae L
    Epilepsia; 2014 Oct; 55(10):1576-84. PubMed ID: 25231724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of children with refractory epilepsy after vagus nerve stimulation in Taiwan.
    Li ST; Chiu NC; Hung KL; Ho CS; Kuo YT; Wu WH;
    Pediatr Neonatol; 2020 Dec; 61(6):606-612. PubMed ID: 32773364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases.
    Elliott RE; Rodgers SD; Bassani L; Morsi A; Geller EB; Carlson C; Devinsky O; Doyle WK
    J Neurosurg Pediatr; 2011 May; 7(5):491-500. PubMed ID: 21529189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy.
    Englot DJ; Rolston JD; Wright CW; Hassnain KH; Chang EF
    Neurosurgery; 2016 Sep; 79(3):345-53. PubMed ID: 26645965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization.
    Sangare A; Marchi A; Pruvost-Robieux E; Soufflet C; Crepon B; Ramdani C; Chassoux F; Turak B; Landre E; Gavaret M
    Brain Connect; 2020 Dec; 10(10):566-577. PubMed ID: 33073582
    [No Abstract]   [Full Text] [Related]  

  • 10. Vagus nerve stimulation therapy for treatment-resistant epilepsy: a 15-year experience at a single institution.
    Galbarriatu L; Pomposo I; Aurrecoechea J; Marinas A; Agúndez M; Gómez JC; Acera MA; Martínez MJ; Valle E; Maestro I; Mateos B; Cabrera A; Fernández J; Iturri F; Garamendi I
    Clin Neurol Neurosurg; 2015 Oct; 137():89-93. PubMed ID: 26164349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term effect of vagus nerve stimulation in pediatric intractable epilepsy: an extended follow-up.
    Serdaroglu A; Arhan E; Kurt G; Erdem A; Hirfanoglu T; Aydin K; Bilir E
    Childs Nerv Syst; 2016 Apr; 32(4):641-6. PubMed ID: 26767841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of vagus nerve stimulation and responsive neurostimulation used in combination for multifocal and generalized onset epilepsy in pediatric patients.
    Beaudreault CP; Spirollari E; Naftchi AF; Sukul V; Das A; Vazquez S; Wolf SM; McGoldrick PE; Muh CR
    J Neurosurg Pediatr; 2023 Jun; 31(6):565-573. PubMed ID: 36933267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficiency between VNS and ANT-DBS therapy in drug-resistant epilepsy: A one year follow up study.
    Zhu J; Wang X; Xu C; Zhang X; Qiao L; Zhang X; Yan X; Ni D; Yu T; Zhang G; Li Y
    J Clin Neurosci; 2021 Aug; 90():112-117. PubMed ID: 34275533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vagus nerve stimulation in managing drug-resistant absence epilepsy syndromes.
    Wessel C; Candan FU; Panah PY; Karia S; Sah J; Mutchnick I; Karakas C
    Seizure; 2024 Apr; 117():60-66. PubMed ID: 38330751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
    Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
    Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy.
    Tzadok M; Harush A; Nissenkorn A; Zauberman Y; Feldman Z; Ben-Zeev B
    Seizure; 2019 Oct; 71():140-144. PubMed ID: 31326720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry.
    Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF
    Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilepsy duration as an independent predictor of response to vagus nerve stimulation.
    Zhu J; Xu C; Zhang X; Qiao L; Wang X; Zhang X; Yan X; Ni D; Yu T; Zhang G; Li Y
    Epilepsy Res; 2020 Nov; 167():106432. PubMed ID: 32717714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Adverse Events and Outcome in a Series of Patients with Long-Term Follow-Up.
    Morace R; Di Gennaro G; Quarato PP; D'Aniello A; Mascia A; Grammaldo L; De Risi M; Sparano A; Di Cola F; De Angelis M; Esposito V
    Acta Neurochir Suppl; 2017; 124():49-52. PubMed ID: 28120052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.
    Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H
    Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.